Specialty Pharmacy Insights

Rubraca Now Approved to Treat Advanced Ovarian Cancer

This week, the FDA granted accelerated approval to Rubraca™ (rucaparib), an oral therapy for patients with advanced ovarian cancer who have been treated with two or more chemotherapies and whose tumors have deleterious BRCA gene mutation as ...

Read More

Avella Specialty Pharmacy Acquires Oncology Plus

We are excited to announce that Avella has recently acquired Oncology Plus, LLC, a leading provider of patient-specific compounded therapies to oncology practices, hospitals and payors nationwide. With this acquisition, Avella furthers its strategic ...

Read More

Improve Adherence with Smart Pill Bottles for Patients Taking Certain Oral Oncolytics Medications

According to the Network for Excellence in Health Innovation, in the United States, poor medication adherence alone accounts for $290 billion of the annual $750 billion in wasted healthcare spend. In addition, medication non-adherence with complex ...

Read More

Dispensing Excellence: Reference Chart and Mobile App for Oncology Providers

Avella is focused on delivering the most relevant tools and information to our providers and their patients. We are excited to share with you our fifth edition of Dispensing Excellence, a publication for healthcare providers, nurses, medical ...

Read More

[Video] How Providers Can Use the Oral Oncology Medication Mobile App

In the past two years alone, 25 new oncology medications have been approved by the FDA. That's the good news. The challenge is that staying up to date with all of the latest information about these drugs takes a lot of your time...time that could be ...

Read More

Venclexta Now Approved to Treat Chronic Lymphocytic Leukemia

This month, the FDA approved Venclexta™ for the treatment of patients with chronic lymphocytic leukemia (CLL) with a chromosomal abnormality called 17p deletion, as detected by an FDA-approved test, who have been treated with at least one prior ...

Read More

Introducing the Oncology Medication Mobile App

mHealth (mobile health) is becoming increasingly important for patient health. At Avella, we believe that having immediate access to information about medications and treatment regimens increases healthcare efficiencies, enhances the patient ...

Read More

FDA Approves Expanded Imbruvica Indication

Chronic Lymphocytic Leukemia (CLL) is a slow-progressing cancer of the bone marrow and blood and is the most common leukemia diagnosed in adults in western countries. The prevalence of CLL is approximately 115,000 patients in the U.S.1 with ...

Read More

How to Cope with a Cancer Diagnosis

Receiving a cancer diagnosis is an emotional experience for you, your family and your friends. Feelings of anger, frustration, and fear are normal. For most people, proactively addressing the diagnosis then exploring the options is the most ...

Read More

What is Infusion Therapy & What Diseases Does it Treat?

Sometimes when people become very ill with a complex disease, they cannot eat, let alone take medications orally. In addition, some medications cannot be given orally because the stomach acids will destroy them, and they will no longer be effective ...

Read More